“Pharmaceutical companies are increasingly relying on signal detection technologies to aid in identifying and managing adverse drug events, says a new report.
According to analysts at the British market research firm Datamonitor, the pharmaceutical industry will see accelerated growth in the uptake of drug safety monitoring technology.
Article
Richard Pizzi, Healthcare IT News, 6 June 2008
